Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandostatin therapy in chronic symptomatic sarcoidosis
NL-OMON25865Recruiting
- Sponsor
- Erasmus MC
- Start
- Jul 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of octreotide in sarcoidosis, sponsored by Erasmus MC. Primary endpoint: Change in uptake on somatostatin receptor scan. Started Jul 2014; status: recruiting.
02
Drugs
octreotide
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on NL-OMON25865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25865.